Meta-analysis of Clinical Outcomes Using Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam for the Treatment of Multidrug-Resistant Gram-Negative Infections

Ceftolozane-tazobactam (C/T), ceftazidime-avibactam (C/A), and meropenem/vaborbactam (M/V) are new beta-lactam/beta-lactamase combination antibiotics commonly used to treat multidrug-resistant Pseudomonas aeruginosa (MDRPA) and carbapenem-resistant Enterobacteriaceae (CRE) infections. This review re...

Full description

Saved in:
Bibliographic Details
Published in:Open Forum Infect Dis
Main Authors: Wilson, Geneva M, Fitzpatrick, Margaret, Walding, Kyle, Gonzalez, Beverly, Schweizer, Marin L, Suda, Katie J, Evans, Charlesnika T
Format: Artigo
Language:Inglês
Published: Oxford University Press 2021
Subjects:
Review Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7875326/
https://ncbi.nlm.nih.gov/pubmed/33598503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa651
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items